1.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: 0559/07, NCT00803907
|
|
2.
|
Phase: Phase IV Type: Prevention, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 09US05N375-Gold, NCT01203878
|
|
3.
|
Phase: Phase IV Type: Prevention, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 10-0933, NCT01229319
|
|
4.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: GW01-1001, NCT01413763
|
|
5.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: IPDTAKOTR/V06/28.12.11, NCT01538901
|
|
6.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Trial Photoderm Graz 2010-1, NCT01088737
|
|
7.
|
Phase: Phase III Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SYM 2012-01, NCT01686152
|
|
8.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Luc 10-002, NCT01191034
|
|
9.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: ITIC2, NCT01283763
|
|
10.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: NYU 11-00598, 1R01CA161891-01, NCT01421017
|
|
11.
|
Phase: Phase II Type: Supportive care Status: Active Age: Not specified Sponsor: Other Protocol IDs: Eudract number: 2006-004902-16, LREC number: 06/Q2201/143, NCT00596336
|
|
12.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 6578, NCI-2010-00040, R01CA138521, 131, UWCC-6578, FHCRC-6578, IR-6578, NCT00821964
|
|
13.
|
Phase: Phase II Type: Prevention Status: Active Age: 18 to 50 Sponsor: Other Protocol IDs: _1.0, ISRCTN: 2008-004893-42, NCT00941811
|
|
14.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 10-000202, NCT01204684
|
|
15.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MM1120, NCT01543464
|
|
16.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: JHOC-J0656, J0656, NA_00002176, NCT00788164
|
|
17.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: LU 1006 - IDO, NCT01219348
|
|
18.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: IMA950-102, 11C0192, NCT01403285
|
|
19.
|
Phase: Phase I Type: Treatment Status: Active Age: 3 to 25 Sponsor: Other Protocol IDs: 2009LS136, 1004M81213, NCT01400672
|
|
20.
|
Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 01 KI 0211, NCT00365729
|
|
21.
|
Phase: No phase specified Type: Treatment Status: Approved-not yet active Age: 49 to 89 Sponsor: Other Protocol IDs: WN07DE002, EudraCT No: 2007-001961-14, NCT00463359
|
|
22.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-347, NCT00865644
|
|
23.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 15168, NCT01264731
|
|
24.
|
Phase: No phase specified Type: Diagnostic, Health services research, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 23592103, NCT01663558
|
|
25.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 11-136, NCT01678352
|